The present article highlights the important progress made in the last two decades in the
fields of molecular imaging and radionuclide therapy. Advancements in radiometal-based …

The growing advancement in nuclear medicine challenges researchers from several
different fields to integrate imaging and therapeutic modalities in a theranostic …

The advent of antibody-based cancer therapeutics has led to the concomitant rise in the
development of companion diagnostics for these therapies, particularly nuclear imaging …

Even today, techentium-99m represents the radionuclide of choice for diagnostic radio-
imaging applications. Its peculiar physical and chemical properties make it particularly …

Molecular changes in malignant tissue can lead to an increase in the expression levels of
various proteins or receptors that can be used to target the disease. In oncology, diagnostic …

Radiometals have become increasingly important because of their use both for diagnostic
molecular imaging and therapy in Nuclear Medicine. The focus is on the study of …

Background 64 Cu is one of the few radioisotopes that can be used for both imaging and
therapy, enabling theranostics with identical chemical composition. Development of stable …

Abstract Technetium-99m (99m Tc) is a radiometal that has nearly ideal nuclear properties
for diagnostic nuclear medicine imaging, which has helped make it high impact and …

Radiometals possess an exceptional breadth of decay properties and have been applied to
medicine with great success for several decades. The majority of current clinical use …

Molecular imaging has evolved over the past several years into an important tool for
diagnosing, understanding, and monitoring disease. Molecular imaging has distinguished …